https://usimmigration.today/tags/biopharma/Recent content in Biopharma on US Immigration, Explained DailyHugoen-USSat, 11 Apr 2026 00:00:00 +0000https://usimmigration.today/news/eb2-niw-approved-for-biopharma-professional-without-phd/Sat, 11 Apr 2026 00:00:00 +0000https://usimmigration.today/news/eb2-niw-approved-for-biopharma-professional-without-phd/<p>A biopharmaceutical professional recently received approval for their EB2 National Interest Waiver (NIW) application, despite lacking a PhD and publications. The individual, who has over 15 years of experience in the biopharma industry and holds a Master of Science in Biotechnology, filed their NIW petition in 2024 and upgraded it to premium processing in late 2025.</p> <p><strong>Key Details:</strong></p> <ul> <li>Application filed: EB2 NIW in 2024, upgraded to premium processing in Q4 2025.</li> <li>Received a Request for Evidence (RFE) in November 2025 focusing on Prongs 1 and 3 of the NIW criteria.</li> <li>Submitted a comprehensive response including an endeavor statement, a detailed response letter, and an independent expert letter.</li> <li>Successfully demonstrated national importance and a well-positioned track record to advance the proposed endeavor.</li> </ul> <p>This case highlights the possibility of obtaining NIW approval without a PhD or publications, provided that applicants can effectively demonstrate their work&rsquo;s national significance and their capability to advance it.</p>